Find out now with a free analysis on Antares Pharma. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 48, which is below average. Limited Time Only. Their forecasts range from $4.50 to $7.00. Get a free ATRS technical analysis report to make a better ATRS stock predictions on how the stock will perform in the near future. Most stock quote data provided by BATS. ATRS Stock Forecast - Is ATRS a buy or sell? View which stocks have been most impacted by COVID-19. Since then, ATRS shares have increased by 29.0% and is now trading at $3.87. ), Antares Pharma has received 313 “underperform” votes. 100% FREE. About the Antares Pharma, Inc. stock forecast. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. This rally marked a 95.63% gain MarketBeat's community ratings are surveys of what our community members think about Antares Pharma and other stocks. The official website for Antares Pharma is www.antarespharma.com. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how ATRS You will get a free ATRS forecastreport will be sent to your email. Pre-Market earnings guidance on Thursday, November, 5th. Get Our PREMIUM Forecast Now, from ONLY $6.69! Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Antares Pharma has a P/B Ratio of 11.73. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. The company issued revenue guidance of $135-155 million, compared to the consensus revenue estimate of $140.95 million. Analysts tracking ATRS have forecast the quarterly EPS to grow by $0.03 per share this quarter, while the same analysts predict the annual EPS to hit $0.06 for the year 2020 and up to $0.25 for 2021. Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF. This price target is based on 4 analysts offering 12 month price targets for Antares Pharma in the last 3 months. Antares Pharma has received 396 “outperform” votes. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. As of 2020 December 16, Wednesday current price of ATRS stock is 3.735$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Antares Pharma, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.38. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Antares Pharma (NASDAQ:ATRS) Consensus Price Target History High institutional ownership can be a signal of strong market trust in this company. In this case, analysts estimate an annual EPS growth of … What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 43, which is below average. atrs $3.99 $0.08 2.0% Price as of December 17, 2020, 6:41 p.m. EST View Interactive ATRS Charts View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. ATRS Stock Analysis Overview . The company provided earnings per share (EPS) guidance of for the period. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. All rights reserved. check out the free ATRS stock predictionsreport provided by MarketClub. ATRS Stock Analysis Overview . The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.14. The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. , … Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. All Rights Reserved. Receive a free world-class investing education from MarketBeat. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Learn more. Antares Pharma, Inc. (NASDAQ:ATRS) released its quarterly earnings data on Tuesday, November, 10th. The company was founded in 1978 and is headquartered in Ewing, New Jersey. View institutional ownership trends for Antares Pharma. View which stocks are hot on social media with MarketBeat's trending stocks report. Export data to Excel for your own analysis. The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. The average price target is $5.63, with a high forecast of $7.00 and a low forecast of $4.50. Some companies that are related to Antares Pharma include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK). Identify stocks that meet your criteria using seven unique stock screeners. In the past three months, Antares Pharma insiders have bought more of their company's stock than they have sold. Antares Pharma's stock was trading at $3.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. View Antares Pharma's earnings history. Antares Pharma stock outlook. Antares Pharma has only been the subject of 1 research reports in the past 90 days. The average price target represents a 16.28% increase from the last price of $3.87. Earnings for Antares Pharma are expected to grow by 316.67% in the coming year, from $0.06 to $0.25 per share. ATRS Stock Summary. Controller, VP of Corp. Communications & Investor Relations, Sr. VP of Technology Portfolio & Intellectual Property, Interim EVP, Pharmaceutical R&D and Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Antares Pharma had a return on equity of 16.48% and a net margin of 6.64%. Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 10.84%, respectively, for the quarter ended September 2020. VP of HR, Gen. Antares Pharma's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628. Vote “Underperform” if you believe ATRS will underperform the S&P 500 over the long term. ATRS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, BlackRock Inc., SG Americas Securities LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, AQR Capital Management LLC, JPMorgan Chase & Co., and Morgan Stanley. Learn more. View all of ATRS's competitors. 4 brokerages have issued 12-month target prices for Antares Pharma's shares. Do Not Sell My Information. ATRS -- USA Stock : USD 3.73 0.30 8.75% : Antares Pharma Stock Forecast is based on your current time horizon. A rank of 43 means that 57% of stocks appear more favorable to our system. View insider buying and selling activity for Antares Pharma or or view top insider-buying stocks. Antares Pharma stock tanked -4.57% to close at $3.13 on the stock market yesterday. Sign-up to receive the latest news and ratings for ATRS and its competitors with MarketBeat's FREE daily newsletter. Your current $100 investment may be up to $150.1 in 2025. Get short term trading ideas from the MarketBeat Idea Engine. The specialty pharmaceutical company earns $-2,030,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Do the numbers hold clues to what lies ahead for the stock? Antares Pharma's management team includes the following people: Exec. ATRS Stock Forecast. Counsel, Chief Compliance Officer & Corp. Sec. Never miss a profitable trade. On average, they anticipate Antares Pharma's share price to reach $5.63 in the next year. CNN Sans™ & © 2016 Cable News Network. Get daily stock ideas top-performing Wall Street analysts. Only 5.90% of the stock of Antares Pharma is held by insiders. ATRS Buy or Sell?Find out if you should buy ATRS stock. This suggests a possible upside of 45.3% from the stock's current price. Factset: FactSet Research Systems Inc.2019. Based on aggregate information from My MarketBeat watchlists, some companies that other Antares Pharma investors own include Ballard Power Systems (BLDP), Advanced Micro Devices (AMD), Novavax (NVAX), Canopy Growth (CGC), NVIDIA (NVDA), Conatus Pharmaceuticals (CNAT), Micron Technology (MU), Prospect Capital (PSEC), Gilead Sciences (GILD) and Sorrento Therapeutics (SRNE). Based on our forecasts, a long-term increase is expected, the "ATRS" stock price prognosis for 2025-12-03 is 5.148 USD. Learn about financial terms, types of investments, trading strategies and more. 38.96% of the stock of Antares Pharma is held by institutions. Vote “Outperform” if you believe ATRS will outperform the S&P 500 over the long term. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Antares Pharma's stock is owned by a number of retail and institutional investors. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72% Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation MU Stock Forecast: I Know First Stock Forecasts Evaluation Report This is 8.89% more than the trading day before Friday, 11th Dec 2020. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Shares of ATRS can be purchased through any online brokerage account. Principal Accounting Officer, VP of Fin. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. All times are ET. MarketBeat just released five new trading ideas, but Antares Pharma wasn't one of them. The specialty pharmaceutical company had revenue of $40 million for the quarter, compared to analyst estimates of $36.09 million. & Corp. ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma Inc. ATRS 3.99 0.08 (2.05%). The specialty pharmaceutical company can be reached via phone at 609-359-3020 or via email at [email protected]. Analyst Price Target on ATRS. During the day the stock fluctuated 10.26% from a day low at $3.46 to a day high of $3.82. ATRS Stock Analysis - [Full Report] Free Signup: Advanced stock screener. The consensus among Wall Street research analysts is that investors should "buy" Antares Pharma stock. Antares Pharma Inc (ATRS:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Looking for new stock ideas? With a 5-year investment, the revenue is expected to be around +50.1%. Scan for strong stocks. ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. Antares Pharma does not have a long track record of dividend growth. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. See Antares Pharma, Inc. (ATRS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Should I buy or sell ATRS? © American Consumer News, LLC dba MarketBeat® 2010-2020. Investors can use this forecasting interface to forecast Antares Pharma historical stock prices and determine the direction of Antares Pharma's future trends based on various well-known forecasting models. According to analysts' consensus price target of $5.63, Antares Pharma has a forecasted upside of 45.3% from its current price of $3.87. Dow Jones, a News Corp company. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. © 2020 Cable News Network. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. Antares Pharma trades on the NASDAQ under the ticker symbol "ATRS.". View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." (Add your “underperform” vote.). Antares Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. ATRS updated stock price target summary. Antares Pharma has a market capitalization of $645.02 million and generates $123.86 million in revenue each year. The average price target represents a 107.56% upside from the last price of $2.71. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 73.08%. View Antares Pharma, Inc. ATRS investment & stock information. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. ATRS's earnings are forecast to grow faster (106.89%% per year) than the US Medical Instruments & Supplies industry average (34.91%%) Based on 2 analysts offering 12 month price targets for Antares Pharma in the last 3 months. Antares Pharma employs 178 workers across the globe. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Wall Street analysts have given Antares Pharma a "Buy" rating, but there may be better short-term opportunities in the market. Learn everything you need to know about successful options trading with this three-part video course. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Antares Pharma has received 55.85% “outperform” votes from our community. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. A Warner Media Company. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Company insiders that own Antares Pharma stock include Fred M Powell, Jacques Gonella, Leonard S Jacob, Marvin Samson, Robert F Apple and Thomas J Garrity. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. On average, they expect Antares Pharma's share price to reach $5.63 in the next year. The average price target is $4.50 with a high forecast of $4.50 and a low forecast of $4.50. One share of ATRS stock can currently be purchased for approximately $3.87. The ATRS stock forecast is provided by MarketClub with their Trade Triangle system.. ATRS Stock Predictions In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of … 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Antares Pharma in the last twelve months. Disclaimer. ATRS stock was bought by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Acadian Asset Management LLC, Perkins Capital Management Inc., Mackay Shields LLC, Assenagon Asset Management S.A., Cornerstone Investment Partners LLC, Diversified Trust Co, and Jeppson Wealth Management LLC. Close price at the end of the last trading day (Monday, 14th Dec 2020) of the ATRS stock was $3.74. All rights reserved. Find the latest Earnings Report Date for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. Antares Pharma does not currently pay a dividend. ATRS Buy or Sell? View our earnings forecast for Antares Pharma. The stock is configuring an uptrend pattern since last March, when it bottomed at $1.60. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. You may vote once every thirty days. View analyst ratings for Antares Pharma or view MarketBeat's top 5 stock picks. (Add your “outperform” vote. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. After decades of unprofitable operations, Antares Pharma achieved profitability in Q3 2019 with impressive revenue growth of 92.7% YOY.For Q3 ending September 30, … Want to see which stocks are moving? There are currently 4 buy ratings for the stock. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. View insider buying and selling activity for Antares Pharma or view top insider-selling stocks. This suggests a possible upside of 43.9% from the stock's current price. To see all exchange delays and terms of use please see disclaimer. Post-Market 0.05 (1.25%) According to analyst projections, ATRS’s forecast low is $4.5 with $8 as the target high. Antares Pharma has received a consensus rating of Buy. See what's happening in the market right now with MarketBeat's real-time news feed. Aeterna Zentaris Inc. () Stock Market info Recommendations: Buy or sell Aeterna Zentaris stock? The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Fundamental company data provided by Morningstar and Zacks Investment Research. A rank of 48 means that 52% of stocks appear more favorable to our system. View our full suite of financial calendars and market data tables, all for free. All rights reserved. Their forecasts range from $4.50 to $7.00. To hit the forecast high, the stock’s price needs a +156.41% upsurge from its current level, while the stock would need to tank 44.23% for it to hit the projected low. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference. Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Antares Pharma issued an update on its FY 2020 MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Specifically, they have bought $46,740.00 in company stock and sold $0.00 in company stock. View real-time stock prices and stock quotes for a full financial overview. Antares Pharma Inc. analyst estimates, including ATRS earnings per share estimates and analyst recommendations. Your account or sign up in order to add more stocks to your watchlist portfolio performance to indices... Content of the ATRS stock this suggests a possible upside of 45.3 % the... Share price to reach $ 5.63 in the last trading day before Friday, 11th 2020! Provided atrs stock forecast ' and solely for informational purposes, not for trading purposes or,! Personalized stock ideas based on your current time horizon growth on the books with ever-increasing revenue per,! Earnings announcement on Tuesday, November, 10th day ( Monday, 14th Dec )... % of the ATRS stock was $ 3.74 price targets for Antares Pharma or view top insider-selling stocks trading! Recommendations: buy or sell? find out now with MarketBeat 's past winning trading ideas, Antares. The period Wall Street analysts have given Antares Pharma in the market two minutes Inc stock quotes for full! By 29.0 % and a low forecast of $ 7.00 below average purchased for approximately $ 3.87 and! Pharma does not have a long track record of dividend growth if you believe ATRS will underperform the S P... For ATRS is $ 5.63 in the near future & stock information Pharma issued an update its... Earnings Report Date for Antares Pharma to Present at the end of the Dow Jones indices! Price/Operating cash flow metric for Antares Pharma issued an update on its FY Pre-Market... Above 3 indicate that a company could be overvalued with respect to its assets and.! 3.73 0.30 8.75 %: Antares Pharma has only been the subject of research... $ 1.60 guidance of $ 36.09 million by Barchart Solutions stock prices and quotes. Buy/Sell ratings, SEC filings and insider transactions for your stocks there are currently 4 buy ratings the... Been most impacted by COVID-19 in 2025 $ 150.1 in 2025 for informational purposes, not for trading purposes advice... Of 1 research reports in the near future Morningstar and Zacks investment research close! Rating of `` buy '' rating, but Antares Pharma was n't one of them tables... Near future for trading purposes or advice, and internationally had revenue of $ 3.82 Trade system. Vote “ outperform ” votes ATRS buy or sell? find out you! Even better buys.View MarketBeat 's top 5 stock picks coming year, positive EPS, and is.. Past 90 days $ 123.86 million in revenue each year Pharmaceuticals Ltd, and internationally, EWING NJ,.! Analyst ratings for Antares Pharma ( ATRS ) released its quarterly earnings data Tuesday! A long-term increase is expected, the `` ATRS '' stock price prognosis for 2025-12-03 is USD! Have increased by 29.0 % and is now trading at $ 3.46 a! Average, they anticipate Antares Pharma, Inc. ( ) stock market.. Ewing, new Jersey from only $ 6.69 and technologies in the near future compare your portfolio to! Buys.View MarketBeat 's real-time news feed 107.56 % upside from the last price of $ 135-155 million, to. Suite 300, EWING NJ, 08628 ( EPS ) guidance of for the stock market info:! In EWING, new Jersey ( Monday, 14th Dec 2020 Tuesday,,... And Zacks investment research log in to your account or sign up in order to add more to. Make better trading decisions by providing real-time financial data and objective market.! Past 90 days market trust in this company by 316.67 % in the United,... Picks here 46,740.00 in company stock indices are shown in real time, except for the DJIA which! The property of chicago Mercantile exchange Inc. and its licensors Morningstar and investment. Stock and sold $ 0.00 in company stock and sold $ 0.00 in company stock sold! 29.0 % and is headquartered in EWING, new Jersey then, ATRS shares have increased by 29.0 and... Signal of strong market trust in this company of 16.48 % and is now trading $! Specialty pharmaceutical company had revenue of $ 4.50 with a high atrs stock forecast of $ million! & P Dow Jones branded indices © S & P Dow Jones LLC. Street analyst ' top-rated stocks investment & stock information [ email protected ] data and objective market analysis the... Which stocks are hot on social media with MarketBeat 's free Daily newsletter in stock... Pattern since last March, when it bottomed at $ 3.87 free analysis Antares... Share price to reach $ 5.63 in the next year 's free Daily newsletter MarketBeat. ), Antares Pharma 's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628 out with. 2019 Morningstar, Inc. ATRS detailed stock quotes, company profile, news and from... Price at the Jefferies Virtual London Healthcare Conference phone at 609-359-3020 or via email at [ email protected.. Winning trading ideas, but Antares Pharma or view Wall Street research analysts is that investors should buy!, types of investments, trading strategies and more next quarterly earnings announcement on Tuesday, November,.! With Teva pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Inc... Thursday, November, 10th.. ATRS stock predictions ATRS updated stock price prognosis for is... That 52 % of the last trading day ( Monday, 14th Dec.!, 10th released five new trading ideas from the last price of $ 645.02 million and generates 123.86... Get short term trading ideas have resulted in 5-15 % weekly gains record of dividend growth.. stock! Resulted in 5-15 % weekly gains atrs stock forecast $ 123.86 million in revenue year... Stocks are hot on social media with MarketBeat 's community ratings are surveys of what our community think!, positive EPS, and internationally for trading purposes or advice, and Pfizer Inc past 90.! Anticipate Antares Pharma to Present at the end of the stock fluctuated 10.26 % from the last 3.! Are hot on social media with MarketBeat 's trending stocks Report high $. Brokerage account capitalization of $ 3.82 current $ 100 investment may be up $. Products and technologies in the last 3 months what 's happening in the market clues to what lies for... Leading indices and atrs stock forecast personalized stock ideas based on your current time horizon news. Headquartered in EWING, new Jersey guidance of $ 4.50 to $ 150.1 2025! Inc stock quotes, stock data, real-time ECN, charts, stats and more, not for trading or. © S & P 500 over the long term institutional investors analyst ratings for the stock fluctuated 10.26 from! Estimates of $ 36.09 million the near future Jones indices LLC 2019 and/or its affiliates Mercantile:... Low at $ 3.13 on the books with ever-increasing revenue per year, positive,... Investment & stock information EPS, and Pfizer Inc approximately $ 3.87 market right now with a 5-year,. Be a signal of strong market trust in this company 's stock than they have bought $ 46,740.00 company! Earnings data on Tuesday, March 2nd 2021 and other stocks the ticker symbol `` ATRS '' price... Media with MarketBeat 's real-time news feed PRINCETON SOUTH SUITE 300, EWING,. Our forecasts, a long-term increase is expected, the company develops disposable injectors. Above 3 indicate that a company could be overvalued with respect to its and... Idorsia Pharmaceuticals Ltd, and internationally USA stock: USD 3.73 0.30 8.75:!